Position in APGE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,962,147
+$832,754 QoQ
Shares Held
14,783
+10.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#158
of 285 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $210,403,156 across 75 Biotechnology names. APGE ranks #28 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
115,233 | $57,239,687 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
45,969 | $28,663,508 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,318 | $11,835,897 | |
| 4 | INCY |
Incyte Corp
|
57,780 | $6,549,940 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,474 | $4,958,050 | |
| 6 | INSM |
INSMED Inc
|
38,766 | $4,133,230 | |
| 7 | MRNA |
Moderna, Inc.
|
55,313 | $3,873,568 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
66,874 | $3,826,530 |
All Filings in APGE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,962,147 | 14,783 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,129,393 | 13,418 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||